PaxMedica, Inc. (PXMD)
OTCMKTS
· Delayed Price · Currency is USD
0.0310
0.00 (0.00%)
Jan 21, 2025, 9:30 AM EST
PaxMedica Employees
As of December 31, 2023, PaxMedica had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees increased by 2 or 40.00% compared to the previous year.
Employees
7
Change (1Y)
2
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$2,522,951
Market Cap
350.68K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 2 | 40.00% |
| Dec 31, 2022 | 5 | 1 | 25.00% |
| Dec 31, 2021 | 4 | -2 | -33.33% |
| Dec 31, 2020 | 6 | 2 | 50.00% |
| Dec 31, 2019 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 2,931 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 413 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 109 |
| SANUWAVE Health | 31 |
PaxMedica News
- 8 days ago - PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions - Accesswire
- 8 days ago - PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions - Accesswire
- 5 months ago - PaxMedica Secures Immediate Exercise of Warrants - Accesswire
- 5 months ago - PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection - Accesswire
- 9 months ago - PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 - GlobeNewsWire
- 9 months ago - PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 - GlobeNewsWire
- 10 months ago - PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness - GlobeNewsWire
- 10 months ago - Why is PaxMedica (PXMD) stock surging today? - Invezz